Jane Street
SIOX

Jane Street’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Jane Street’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,350
Closed -$24K – 5885
2018
Q2 		$24K Buy
+1,350
New +$19.9K ﹤0.01% 4857
2017
Q4 		– Sell
-5,938
Closed -$327K – 5338
2017
Q3 		$327K Buy
+5,938
New +$1M ﹤0.01% 3592

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's SIOX Position: Q4 2022 in Review

Jane Street sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2022, closing a stake of 99,324 shares — an estimated $28K sold.

Jane Street first reported a position in SIOX in Q3 2017 and held it in 9 quarters. The position peaked at $350K in Q2 2018. 37 funds tracked by Wall St. Rank hold SIOX as of Q4 2022.

  • Jane Street reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 99,324 Sio Gene Therapies Inc. Common Stock shares in Q4 2022, an estimated $28K.
  • Jane Street first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • Jane Street's Sio Gene Therapies Inc. Common Stock position peaked at $350K in Q2 2018.
  • 37 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.